VUSION Drug Patent Profile
✉ Email this page to a colleague
When do Vusion patents expire, and when can generic versions of Vusion launch?
Vusion is a drug marketed by Mylan and is included in one NDA. There is one patent protecting this drug.
This drug has one patent family member in one country.
The generic ingredient in VUSION is miconazole nitrate; white petrolatum; zinc oxide. There are twenty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the miconazole nitrate; white petrolatum; zinc oxide profile page.
DrugPatentWatch® Generic Entry Outlook for Vusion
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be March 30, 2028. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VUSION?
- What are the global sales for VUSION?
- What is Average Wholesale Price for VUSION?
Summary for VUSION
International Patents: | 1 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 114 |
Clinical Trials: | 2 |
Patent Applications: | 3,823 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VUSION |
What excipients (inactive ingredients) are in VUSION? | VUSION excipients list |
DailyMed Link: | VUSION at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for VUSION
Generic Entry Date for VUSION*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
OINTMENT;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for VUSION
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Image Dermatology P.C. | Early Phase 1 |
GlaxoSmithKline | Phase 4 |
Stiefel, a GSK Company | Phase 4 |
Pharmacology for VUSION
Drug Class | Azole Antifungal |
US Patents and Regulatory Information for VUSION
VUSION is protected by one US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of VUSION is ⤷ Sign Up.
This potential generic entry date is based on patent ⤷ Sign Up.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting VUSION
Modified azole compounds as antifungal and antibacterial agents
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE FOR TREATMENT OF DIAPER DERMATITIS COMPLICATED BY CANDIDIASIS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | VUSION | miconazole nitrate; white petrolatum; zinc oxide | OINTMENT;TOPICAL | 021026-001 | Feb 16, 2006 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VUSION
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan | VUSION | miconazole nitrate; white petrolatum; zinc oxide | OINTMENT;TOPICAL | 021026-001 | Feb 16, 2006 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VUSION
See the table below for patents covering VUSION around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Zimbabwe | 1185 | SKIN CARE COMPOSITIONS | ⤷ Sign Up |
Mexico | 163628 | UNA COMPOSICION COSMETICA PARA EL CUIDADO DE LA PIEL | ⤷ Sign Up |
European Patent Office | 0149561 | SKIN CARE COMPOSITIONS | ⤷ Sign Up |
South Africa | 8500400 | ⤷ Sign Up | |
Australia | 3775885 | ⤷ Sign Up | |
Philippines | 20480 | SKIN CARE COMPOSITIONS | ⤷ Sign Up |
Ireland | 58380 | Skin care compositions | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |